Similarly, in Parkinson’s disease (PD), both the innate and adaptive immune systems lose competence with aging and are notably altered: inflammation is linked to the degeneration of dopaminergic neurons in the substantia nigra [91], with elevated levels of inflammatory mediators like IL-1β and TNF-α being observed in affected brain regions [92]. Here, IL1B is linked to Parkinson disease.